Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2013 6
2014 4
2015 3
2017 1
2018 3
2019 4
2020 7
2021 9
2022 7
2023 13
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring.
Ashton NJ, Janelidze S, Mattsson-Carlgren N, Binette AP, Strandberg O, Brum WS, Karikari TK, González-Ortiz F, Di Molfetta G, Meda FJ, Jonaitis EM, Koscik RL, Cody K, Betthauser TJ, Li Y, Vanmechelen E, Palmqvist S, Stomrud E, Bateman RJ, Zetterberg H, Johnson SC, Blennow K, Hansson O. Ashton NJ, et al. Among authors: jonaitis em. Nat Med. 2022 Dec;28(12):2555-2562. doi: 10.1038/s41591-022-02074-w. Epub 2022 Dec 1. Nat Med. 2022. PMID: 36456833 Free PMC article.
Plasma phosphorylated tau 217 in preclinical Alzheimer's disease.
Jonaitis EM, Janelidze S, Cody KA, Langhough R, Du L, Chin NA, Mattsson-Carlgren N, Hogan KJ, Christian BT, Betthauser TJ, Hansson O, Johnson SC. Jonaitis EM, et al. Brain Commun. 2023 Mar 6;5(2):fcad057. doi: 10.1093/braincomms/fcad057. eCollection 2023. Brain Commun. 2023. PMID: 37013174 Free PMC article.
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
Mattsson-Carlgren N, Salvadó G, Ashton NJ, Tideman P, Stomrud E, Zetterberg H, Ossenkoppele R, Betthauser TJ, Cody KA, Jonaitis EM, Langhough R, Palmqvist S, Blennow K, Janelidze S, Johnson SC, Hansson O. Mattsson-Carlgren N, et al. Among authors: jonaitis em. JAMA Neurol. 2023 Apr 1;80(4):360-369. doi: 10.1001/jamaneurol.2022.5272. JAMA Neurol. 2023. PMID: 36745413 Free PMC article.
CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic Challenges.
Jonaitis EM, Jeffers B, VandenLangenberg M, Ma Y, Van Hulle C, Langhough R, Du L, Chin NA, Przybelski RJ, Hogan KJ, Christian BT, Betthauser TJ, Okonkwo OC, Bendlin BB, Asthana S, Carlsson CM, Johnson SC. Jonaitis EM, et al. Clin Chem. 2024 Mar 2;70(3):538-550. doi: 10.1093/clinchem/hvad221. Clin Chem. 2024. PMID: 38431278 Free PMC article.
Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease.
Panyard DJ, McKetney J, Deming YK, Morrow AR, Ennis GE, Jonaitis EM, Van Hulle CA, Yang C, Sung YJ, Ali M, Kollmorgen G, Suridjan I, Bayfield A, Bendlin BB, Zetterberg H, Blennow K, Cruchaga C, Carlsson CM, Johnson SC, Asthana S, Coon JJ, Engelman CD. Panyard DJ, et al. Among authors: jonaitis em. Alzheimers Dement. 2023 Dec;19(12):5447-5470. doi: 10.1002/alz.13130. Epub 2023 May 22. Alzheimers Dement. 2023. PMID: 37218097 Free PMC article.
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.
Salvadó G, Larsson V, Cody KA, Cullen NC, Jonaitis EM, Stomrud E, Kollmorgen G, Wild N, Palmqvist S, Janelidze S, Mattsson-Carlgren N, Zetterberg H, Blennow K, Johnson SC, Ossenkoppele R, Hansson O. Salvadó G, et al. Among authors: jonaitis em. Alzheimers Dement. 2023 Jul;19(7):2943-2955. doi: 10.1002/alz.12907. Epub 2023 Jan 17. Alzheimers Dement. 2023. PMID: 36648169 Free PMC article.
Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.
Erickson P, Simrén J, Brum WS, Ennis GE, Kollmorgen G, Suridjan I, Langhough R, Jonaitis EM, Van Hulle CA, Betthauser TJ, Carlsson CM, Asthana S, Ashton NJ, Johnson SC, Shaw LM, Blennow K, Andreasson U, Bendlin BB, Zetterberg H; ADNI Cohort. Erickson P, et al. Among authors: jonaitis em. JAMA Neurol. 2023 Jul 31;80(9):969-79. doi: 10.1001/jamaneurol.2023.2338. Online ahead of print. JAMA Neurol. 2023. PMID: 37523162 Free PMC article.
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology.
Ossenkoppele R, Salvadó G, Janelidze S, Binette AP, Bali D, Karlsson L, Palmqvist S, Mattsson-Carlgren N, Stomrud E, Therriault J, Rahmouni N, Rosa-Neto P, Coomans EM, van de Giessen E, van der Flier WM, Teunissen CE, Jonaitis EM, Johnson SC; PREVENT-AD Research Group; Villeneuve S, Benzinger TLS, Schindler SE, Bateman RJ, Doecke JD, Doré V, Feizpour A, Masters CL, Rowe C, Wiste HJ, Petersen RC, Jack CR Jr, Hansson O. Ossenkoppele R, et al. Among authors: jonaitis em. medRxiv [Preprint]. 2024 Jun 13:2024.06.12.24308824. doi: 10.1101/2024.06.12.24308824. medRxiv. 2024. PMID: 38947004 Free PMC article. Preprint.
Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sample.
Du L, Langhough RE, Wilson RE, Reyes RER, Hermann BP, Jonaitis EM, Betthauser TJ, Chin NA, Christian B, Chaby L, Jeromin A, Molfetta GD, Brum WS, Arslan B, Ashton N, Blennow K, Zetterberg H, Johnson SC. Du L, et al. Among authors: jonaitis em. Alzheimers Dement. 2024 Sep;20(9):6183-6204. doi: 10.1002/alz.14100. Epub 2024 Jul 5. Alzheimers Dement. 2024. PMID: 38970274 Free PMC article.
Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography.
Coughlan GT, Betthauser TJ, Boyle R, Koscik RL, Klinger HM, Chibnik LB, Jonaitis EM, Yau WW, Wenzel A, Christian BT, Gleason CE, Saelzler UG, Properzi MJ, Schultz AP, Hanseeuw BJ, Manson JE, Rentz DM, Johnson KA, Sperling R, Johnson SC, Buckley RF. Coughlan GT, et al. Among authors: jonaitis em. JAMA Neurol. 2023 May 1;80(5):462-473. doi: 10.1001/jamaneurol.2023.0455. JAMA Neurol. 2023. PMID: 37010830 Free PMC article.
60 results